Endothelial Progenitor Cells: Therapeutic Target for Cardiovascular Diseases
Circulating endothelial progenitor cells (EPCs) derived from bone marrow were isolated for the first time in 1997 and characterized. Recent evidence has indicated that EPCs contribute to reendothelialization of injured vessels as well as neovascularization of ischemic lesions and that a decrease in...
Saved in:
Main Authors: | Takashi Umemura (Author), Yukihito Higashi (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2008-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Endothelial Progenitor Cells for Diagnosis and Prognosis in Cardiovascular Disease
by: Caterina Oriana Aragona, et al.
Published: (2016) -
Roles of Oxidative Stress and Inflammation in Vascular Endothelial Dysfunction-Related Disease
by: Yukihito Higashi
Published: (2022) -
The Role of Endothelial Progenitor Cell in Cardiovascular Disease Risk Factors
by: Rahmawati Minhajat, et al.
Published: (2016) -
Endothelial Progenitor Cells and Kidney Diseases
by: Abdullah Ozkok, et al.
Published: (2018) -
Pivotal Cytoprotective Mediators and Promising Therapeutic Strategies for Endothelial Progenitor Cell-Based Cardiovascular Regeneration
by: Hyunyun Kim, et al.
Published: (2016)